4D Molecular Therapeutics Inc

NAS:FDMTHealthcareCBOEFTSE:MRUTNASDAQ:NBI

$12.75+3.74%LiveIn session · ≈ AED 46.82 · Market cap $704.36M · Next earnings Tue 10 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	−289.6%	−240.2%	−2,464.8%	−368.5%	−381,789.2%	91.1%	—	—
Operating margin	−416.3%	−395.5%	−3,516.5%	−544.6%	−507,678.4%	−187.2%	−187.2%	+0.0 pts
Net margin	−416.5%	−395.4%	−3,435.4%	−486.6%	−434,778.4%	−164.4%	−164.4%	+0.0 pts
EBITDA margin	−405.7%	−386.9%	−3,358.6%	−466.3%	−416,656.8%	−155.5%	—	—
Return on equity	−22.1%	−22.3%	−46.5%	−32.8%	−31.5%	−27.7%	−27.7%	+0.0 pts
Return on assets	−19.7%	−20.2%	−41.1%	−29.7%	−28.7%	−24.7%	−24.7%	+0.0 pts
Return on capital employed	−20.9%	−21.2%	−44.7%	−35.2%	−35.4%	−30.5%	—	—
Debt / equity	0.0×	0.1×	0.1×	0.0×	0.0×	0.0×	0.0×	+0.0%
Debt / assets	0.0%	4.7%	6.2%	4.3%	4.4%	3.8%	—	—
Interest coverage	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Current ratio	16.9×	15.7×	14.0×	15.7×	14.9×	9.4×	9.4×	+0.0%
Quick ratio	16.9×	15.7×	14.0×	15.7×	14.9×	9.4×	—	—
Cash ratio	16.5×	9.4×	3.3×	13.1×	5.1×	1.4×	1.4×	+0.0%
Asset turnover	0.0×	0.1×	0.0×	0.1×	0.0×	0.2×	—	—
Receivables turnover	9.2×	383.8×	4.5×	—	—	—	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.